# The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)

> **NCT00359216** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 30 (actual)

## Conditions studied

- Perennial Allergic Rhinitis
- Obstructive Sleep Apnea
- Sleep Disorder

## Interventions

- **DRUG:** Mometasone furoate nasal spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00359216
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359216, "The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00359216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*